Skip to main content

Now FDA-approved for adults with relapsed or refractory diffuse
large B-cell lymphoma after 2 prior treatments and who are not
candidates for stem cell transplant (HSCT) or CAR-T therapy

ADCETRIS + LENALIDOMIDE + RITUXIMAB MAY TO HELP WHEN DLBCL DOESN'T BACK DOWN

Explore the study data

For adults with previously untreated Stage 3
or 4 classical Hodgkin lymphoma (cHL),

ADCETRIS + AVD MAYCHANGE YOUR FUTURE

Explore the long-term study data

Amina, Mary Ann, and Justin were treated with ADCETRIS + AVD

Adult Classical
Hodgkin Lymphoma Certain Diffuse Large
B-cell Lymphomas Pediatric Classical
Hodgkin Lymphoma Certain T-cell
Lymphomas

For Healthcare Professionals

Efficacy data from ECHELON-1 are impacting the future of treatment for adults with previously untreated Stage III/IV adult cHL.

See the data

AVD: A combination of 3 chemotherapies—Adriamycin, vinblastine, and dacarbazine.

ADCETRIS will not work for everyone. Individual results may vary.

Adult Classical Hodgkin LymphomaCertain Diffuse Large B-cell LymphomasPediatric Classical Hodgkin LymphomaCertain T-cell Lymphomas